开设账户
模拟账户
关于我们
即时报价及新闻
市场分析
财经日历
每日市场分析
交易平台
下载及介绍
使用教学
交易细则
各项细则
资金提存
推广和资讯
常见问题
联络我们
繁
简
EN
客户登入
开设账户
模拟账户
繁
简
EN
客户登入
开设账户
模拟账户
关于我们
上志国际介绍
上志国际优势
即时报价及新闻
即时报价
即时新闻
市场分析
财经日历
市场分析
交易平台
平台特点
平台教学
交易细则
各项细则
资金提存
推广和资讯
常见问题
联络我们
关于我们
交易细则
贵金属市场
交易平台
市场分析
推广和资讯
常见问题
联络我们
繁
简
EN
美国商品期货交易委员会(CFTC):截至7月7日当周,COMEX黄金投机者将净多头头寸减少1,964手至114,854手。COMEX白银投机者将净多头头寸减少616手至12,131手。COMEX铜投机者将净多头头寸减少970手至60,397手。
2026-07-11
美国商品期货交易委员会(CFTC):截至7月7日当周,COMEX黄金投机者将净多头头寸减少1,964手至114,854手。COMEX白银投机者将净多头头寸减少616手至12,131手。COMEX铜投机者将净多头头寸减少970手至60,397手。
返回
其他消息
2026-07-10
Tickmill Group analyst Patrick Munnelly said SK Hynix's $26.5 bln US depositary receipt sale should help fund its AI compute infrastructure investments. He said investors want concrete drivers in earnings season — financing, capacity expansion, data-centre demand and hardware bottlenecks — rather than abstract AI hype. Renewed buying of Hynix and other Korean chip names suggests the market treats the AI upswing as structural, not just momentum. Korea remains a key barometer of AI-hardware risk a
Tickmill Group analyst Patrick Munnelly said SK Hynix's $26.5 bln US depositary receipt sale should help fund its AI compute infrastructure investments. He said investors want concrete drivers in earnings season — financing, capacity expansion, data-centre demand and hardware bottlenecks — rather than abstract AI hype. Renewed buying of Hynix and other Korean chip names suggests the market treats the AI upswing as structural, not just momentum. Korea remains a key barometer of AI-hardware risk appetite, and the recent pullback has provided a clearer entry for investors who expect earnings to validate a capex cycle.
2026-07-10
Hong Kong-listed pharmaceutical outsourcing/CRO names rallied: 06127.HK rose over 6%, 03759.HK rose over 5%, WuXi AppTec (02359.HK) and Tigermed (03347.HK) rose over 4%, and WuXi Biologics (02269.HK) rose over 3%.
Hong Kong-listed pharmaceutical outsourcing/CRO names rallied: 06127.HK rose over 6%, 03759.HK rose over 5%, WuXi AppTec (02359.HK) and Tigermed (03347.HK) rose over 4%, and WuXi Biologics (02269.HK) rose over 3%.
Chat with us
, powered by
LiveChat